Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IMMUNOTHERAPY”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04177810
What this trial is testing

Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Testing effectiveness (Phase 2)Study completedNCT02285413
What this trial is testing

Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients

Who this might be right for
Melanoma
Radboud University Medical Center 54
Testing effectiveness (Phase 2)Looking for participantsNCT06045910
What this trial is testing

A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, Large B-Cell, DiffuseLymphoma, Mantle-Cell+3 more
Cancer Research UK 84
Not applicableNot Yet RecruitingNCT07665697
What this trial is testing

Analysis of Efficacy and Outcomes of Immunotherapy for Malignant Tumors: A Prospective Non-interventional Clinical Study

Who this might be right for
NeoplasmsDrug TherapyImmune Checkpoint Inhibitors (ICIs)
Sichuan University 500
Testing effectiveness (Phase 2)UnknownNCT04776590
What this trial is testing

Chemoradiotherapy Plus Immunotherapy Followed by Surgery for Esophageal Cancer

Who this might be right for
Esophagus CancerNeoadjuvant Therapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Not applicableStudy completedNCT01752010
What this trial is testing

Comparing Acupuncture, BioModulator, and Transcutaneous Electrical Nerve Stimulation for Symptomatic Treatment of Chronic Pain.

Who this might be right for
Chronic PainDepressionPTSD Symptoms+1 more
Samueli Institute for Information Biology 98
Testing effectiveness (Phase 2)WithdrawnNCT06765954
What this trial is testing

Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.

Who this might be right for
High-risk Prostate Cancer
ImmunityBio, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT06716853
What this trial is testing

A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma

Who this might be right for
Clear Cell RCC
Genenta Science 10
Testing effectiveness (Phase 2)Study completedNCT03878472
What this trial is testing

Neoadjuvant Immunotherapy for Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Qilu Hospital of Shandong University 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07767266
What this trial is testing

Neoadjuvant Pucotenlimab and Becotatug Vedotin for Locally Advanced Penile Cancer

Who this might be right for
Penile CancerPenile Squamous Cell Carcinoma (PSCC)
Sun Yat-sen University 29
Not applicableStudy completedNCT01275456
What this trial is testing

Validation of an Environmental Exposure Chamber for Inhalation Studies With House Dust Mite Allergen in Patients With Allergic Rhinitis

Who this might be right for
Allergy to House Dust Mite
Fraunhofer-Institute of Toxicology and Experimental Medicine 18
Large-scale testing (Phase 3)Not Yet RecruitingNCT07653451
What this trial is testing

Precision Medicine for Immunotherapy-Resistant Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University Cancer Hospital & Institute 90
Large-scale testing (Phase 3)Looking for participantsNCT07678229
What this trial is testing

BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL

Who this might be right for
Extranodal NK/T-cell Lymphoma
Rong Tao 150
Testing effectiveness (Phase 2)Looking for participantsNCT07502287
What this trial is testing

Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaHigh-Risk Neuroblastoma+1 more
Beijing Biotech 36
Testing effectiveness (Phase 2)Study completedNCT00194714
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab

Who this might be right for
HER2/Neu PositiveHLA-A2 Positive Cells PresentStage IV Breast Cancer+1 more
University of Washington 22
Testing effectiveness (Phase 2)UnknownNCT02906163
What this trial is testing

First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy

Who this might be right for
EGFR Mutation Positive Non Small Cell Lung Cancer
SciClone Pharmaceuticals 188
Testing effectiveness (Phase 2)UnknownNCT04714593
What this trial is testing

Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic Leukemia

Who this might be right for
Acute Lymphocytic Leukemia， B-Cell
Shanxi Province Cancer Hospital 24
Early research (Phase 1)Looking for participantsNCT07076498
What this trial is testing

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

Who this might be right for
Glioma
M.D. Anderson Cancer Center 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07486687
What this trial is testing

Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy

Who this might be right for
Triple Negative Breast Cancer (TNBC), Early SettingEarly Stage Triple-Negative Breast CarcinomaTriple -Negative Breast Cancer+2 more
The Netherlands Cancer Institute 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT03395587
What this trial is testing

Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Heinrich-Heine University, Duesseldorf 136
Next Page